By Katharine Lang Evidence is growing that a common antidepressant may reduce the severity of symptoms and mortality following SARS-CoV-2 infection.In an observational study, patients taking selective serotonin reuptake inhibitors (SSRIs) were 8% less likely to die...
Common antidepressant may reduce COVID-19 death risk
read more